Composition
- Active ingredients
- NIACIN 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NIACIN 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseNDA020381-003 · Discontinued
- NIACIN 375MG · Tablet, extended releaseNDA020381-001 · Discontinued
- NIACIN 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseNDA020381-004 · Discontinued
- NIACIN 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020381.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Niaspan
- Active substance
- niacin
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Abbvie
- Status
- Discontinued
- FDA approval
- 28 Jul 1997
- Application
- NDA020381-002